What Will be the Forecasted Market Size and Growth Rates for The Global Cardiac Biomarkers Testing Market?
The cardiac biomarkers testing market size has dramatically grown in recent years. It is forecasted to amplify from $13.48 billion in 2024 to $15.09 billion in 2025 with a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period is largely due to the increasing incidence of cardiovascular diseases, the aging population, awareness and education initiatives, and government healthcare policies leading to massive healthcare expenditure. The market size is slated to skyrocket to $23.75 billion in 2029 at a CAGR of 12.0%, driven by personalized medicine, burgeoning global rates of cardiovascular diseases, artificial intelligence integration in diagnostics, point-of-care testing expansion, early disease detection emphasis and significant advancements in technology.
Get your Free Sample of The Global Cardiac Biomarkers Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
How is the Growth of Cardiovascular Diseases Driving the Cardiac Biomarkers Testing Market?
Cardiovascular diseases’ increasing prevalence is anticipated to catalyze the growth of the cardiac biomarkers testing market. Heart or blood vessel affecting diseases, known as cardiovascular diseases require cardiac biomarker tests to immediately determine the heart attack’s magnitude and severity. For instance, as per the American College of Cardiology, the rates of cardiovascular risk factors and disease are expected to significantly surge in the US by the year 2060. This rise will directly lead to heightened demand for cardiac biomarker testing solutions, thereby driving the market growth.
What are the Noteworthy Segments in the Global Cardiac Biomarkers Testing Market?
The cardiac biomarkers testing market is segmented into:
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Who are the Key Companies Transforming the Cardiac Biomarkers Testing Market?
Major players in the cardiac biomarkers testing market encompass Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation.
What Emerging Trends are Dominating the Cardiac Biomarkers Testing Market?
Companies in the cardiac biomarker testing market sphere are investing in strategic partnerships to offer enhanced technology for early heart condition detection and improved patient outcomes. These partnerships bolster collaboration, facilitating innovative diagnostic development and extended market reach, and expedite the availability of advanced testing solutions. For instance, the India-based healthcare technology company MediBuddy teamed up with Philips in September 2024 to strengthen cardiac care in India using Philips’ HeartPrint technology, which enables regular heart health monitoring and risk assessment. Such proactive improvements in patient outcomes through advanced tools are expected to drive the market growth.
Which Regions are Leading the Global Cardiac Biomarkers Testing Market?
North America had the lion’s share in the cardiac biomarkers testing market in 2024. Besides North America, the market report also covers other significant regions including Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
What Does The Cardiac Biomarkers Testing Market Report 2025 Offer?
The Cardiac Biomarkers Testing Market research report from The Business Research Company presents the global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. Cardiac biomarkers testing entails the evaluation of cardiac biomarker quantities in the blood, which is crucial for diagnosing, assessing, and monitoring patients who may have acute coronary syndrome (ACS).
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
